For those living with joint pain, there’s some good news. A recent study suggests that a pill called colchicine might help ...

The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. | Following some ...

Colchicine, a cheap and readily available anti-inflammatory drug used to treat diseases such as gout, is to be investigated as a potential therapy for COVID-19 in the UK’s ground-breaking ...

The current target of gout treatment is to reduce levels down to ... Amgen reported sales of $272 million for the drug after it took ownership in 2023 and $235 million in the first quarter of ...

The drugs listed are in alphabetical order. Bendamustine hydrochloride injection: Apotex on Jan. 27 reported the discontinuation of both the 25 mg and 100 mg presentations of bendamustine ...

Several drug classes are commonly used to treat MDD, including antidepressants, antipsychotics, anti-anxiety medications, and other types of mood-stabilizing drugs. This variety of classes can help ...

Reduce CV Event Risk with Urate-Lowering Therapy for Gout, suggests a study published in The Lancet Rheumatology.Researchers ...

If you don't have symptoms, you don't necessarily need to treat your high uric acid levels. When hyperuricemia symptoms are present, a change in diet may help. Medication is typically prescribed for ...

Takeda is promoting U.S. chief Julie Kim to be its next CEO. AstraZeneca and Daiichi's Enhertu has won an FDA nod to expand into HER2-ultralow breast cancer. | Takeda is promoting U.S. chief Julie Kim ...

CALGARY, Alberta, Jan. 29, 2025 (GLOBE NEWSWIRE) -- ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA) ...

A recent study by researchers from the University of California San Diego and collaborators has uncovered a new molecular ...

Among patients with gout in the US, Black individuals and those living in the South were associated with reduced adherence to allopurinol.